Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

The efficacy of topical prophylactic antiglaucoma therapy in primary closed angle glaucoma in dogs: a multicenter clinical trial.

Miller PE, Schmidt GM, Vainisi SJ, Swanson JF, Herrmann MK.

J Am Anim Hosp Assoc. 2000 Sep-Oct;36(5):431-8.

PMID:
10997520
2.

Are there any benefits of Betoptic S (betaxolol HCl ophthalmic suspension) over other beta-blockers in the treatment of glaucoma?

Yarang├╝meli A, Kural G.

Expert Opin Pharmacother. 2004 May;5(5):1071-81. Review.

PMID:
15155109
3.

Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension.

Buckley MM, Goa KL, Clissold SP.

Drugs. 1990 Jul;40(1):75-90. Review.

PMID:
2202584
4.

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.

PMID:
12795627
5.

Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Brooks AM, Gillies WE.

Drugs Aging. 1992 May-Jun;2(3):208-21. Review.

PMID:
1351412
6.

Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade.

Frishman WH, Kowalski M, Nagnur S, Warshafsky S, Sica D.

Heart Dis. 2001 Nov-Dec;3(6):386-97. Review.

PMID:
11975823
Items per page

Supplemental Content

Write to the Help Desk